Bacillus Calmette–Guérin and anti-PD-L1 combination therapy boosts immune response against bladder cancer

BACKGROUND: Programmed death-ligand 1 (PD-L1) is a critical immune checkpoint molecule which promotes immunosuppression by binding to PD-1 on T-cells in tumor immunity. We have previously identified that activation of toll like receptor 4 (TLR-4), which serves an important role in the induction of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yonghua, Liu, Jing, Yang, Xuecheng, Liu, Yanan, Liu, Yong, Li, Yanjiang, Sun, Lijiang, Yang, Xiaokun, Niu, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962256/
https://www.ncbi.nlm.nih.gov/pubmed/29844686
http://dx.doi.org/10.2147/OTT.S165840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962256/
https://www.ncbi.nlm.nih.gov/pubmed/29844686
http://dx.doi.org/10.2147/OTT.S165840

Ejemplares similares